Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer

Clinical guideline
Reference number: CG164
Published: 25 June 2013
Last updated: 14 November 2023

Register as a stakeholder

Familial breast cancer (update): NICE version

Familial breast cancer (update): NICE version

Familial breast cancer (update): NICE version
15 January 2013
(678.2 Kb 17 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 14 January 2013

Stakeholder list (PDF 48 KB)

Published:

09 October 2017
Familial breast cancer (update): Equality Impact Assessment form (PDF 61 KB)

Published:

25 June 2013
Familial breast cancer (update): guideline consultation comments with responses (PDF 1.39 MB)

Published:

25 June 2013
Scoping equalities impact assessment form (PDF 66 KB)

Published:

12 November 2013
Scope (PDF 64 KB)

Published:

06 July 2011
Scope consultation table (PDF 199 KB)

Published:

06 July 2011
Draft scope (PDF 73 KB)

Published:

31 March 2011
Stakeholder list (PDF 42 KB)

Published:

11 September 2012
Familial breast cancer (update): full version (PDF 3.63 MB)

Published:

15 January 2013
Familial breast cancer (update): appendices (PDF 888 KB)

Published:

15 January 2013
Familial breast cancer (update): NICE version (PDF 678 KB)

Published:

15 January 2013
Familial breast cancer (update): full evidence review (PDF 9.37 MB)

Published:

15 January 2013
Familial breast cancer (update): full evidence review reports for health economics (PDF 4.44 MB)

Published:

15 January 2013
Familial breast cancer (update): needs assessment full report (PDF 1.32 MB)

Published:

15 January 2013
Clinical questions (PDF 182 KB)

Published:

27 September 2012
Economic health plan (PDF 105 KB)

Published:

27 September 2012
Search strategies (PDF 524 KB)

Published:

27 September 2012
GDG membership list (PDF 45 KB)

Published:

05 December 2011
GDG 2 minutes (PDF 38 KB)

Published:

22 December 2011
GDG 1 minutes (PDF 43 KB)

Published:

02 December 2011
Remit (PDF 17 KB)

Published:

08 November 2010